NIH Bioanalysis Testing Services 2015-2020

The NIH Bioanalysis Testing Services 2015-2020 Master Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle was established by the National Institutes of Health (NIH) to provide specialized bioanalytical research services. Specifically, the contract supports preclinical drug discovery and development through comprehensive testing services, focusing on pharmacokinetic assessments, toxicity studies, and chemical analysis. The solicitation indicates the primary scope involves bioanalysis testing services, including microsomal stability testing, which encompasses evaluations of absorption, distribution, metabolism, and excretion (ADME) processes across various biological systems.

The task orders under this contract vehicle predominantly feature firm fixed-price delivery orders ranging from approximately $3,000 to $1,109,620, with most contracts having an ultimate completion date of September 14, 2020. Frequent prime contractors included Pharmaron, Inc., OPANS, LLC, Quintara Discovery, Inc., and Crown Bioscience, Inc., with work primarily performed for agencies such as the National Institute on Drug Abuse (NIDA) and the National Center for Advancing Translational Sciences (NCATS). None of the task orders utilized set-aside designations, suggesting open competition. The contract vehicle facilitated preclinical research activities across global locations, including facilities in the United States and China, supporting drug development initiatives in areas such as metabolic disorders, cancer research, and potential therapeutic interventions.